The Medical Affairs and Clinical Development team at Vertex Pharmaceuticals is responsible for overseeing the clinical trials and development of novel small molecule drugs. This team ensures the safety and efficacy of treatments through rigorous clinical testing, data management, and patient safety oversight. Additionally, they engage with the medical community and patients to facilitate education and communication about Vertex's clinical programs and commercialized products.
Adam Haeberle Mba
Program Lead Clinical Scientis...
Alexandra Chabrerie
Associate Medical Director - C...
Ali Mohamadi
Vice President, Medical Affair...
Aric Parnes
Medical Director
Bryan King
Sr. Director, National Lead US...
Danielle Shockley
Clinical Operations Program Le...
David Bishop
Disease Area Executive And VP ...
Fosca de Iorio
Vice President Global Medical ...
Francesca Cardarelli
Senior Medical Director Clinic...
Hildegarde Paz
Asociate Medical Director. Cli...
Jean-Marc Guettier
Svp, Head Of Clinical Developm...
John Staropoli
Senior Medical Director, Trans...
Kilpatrick Carroll
Vice President And US Hematolo...
Ling-Fang Tseng
Clinical Safety Senior Manager
Manasi Sinha Jaiman
Vice President Vertex, Chief M...
Mark Garrett
Clinical Operations Study Lead
Martin Whittle
Principal Clinical Scientist
Martyn Botfield
Vice President, Translational ...
Mary Paty Mahoney
Clinical Trial Management, Man...
Meg Duncan
Executive Medical Director, US...
Nicoline Schaap
Principal Clinical Scientist
Partha Ray
Medical Director
Paula Orlandi
Clinical Development Medical D...
Rebecca Hunt
Vice President, Patient And Co...
Sasanka Vallabhaneni
Lead Clinical Data Manager
Sebastian Sorsaburu
Vice President, Medical Affair...
Simon Tian
Vp, Head Of Global Patient Saf...
Staci Luca
Associate Director Clinical Da...
Tauqeer Karim
Medical Director, Global Patie...
Tracy Bunting-Early
Director, Global Medical Affai...
Yvonne Fok
Medical Education Lead Cf, Med...
View all